Central nervous system effects of haloperidol on THC in healthy male volunteers (Q43168358)

15 November 2017

Central nervous system effects of haloperidol on THC in healthy male volunteers (English)

1 reference

15 November 2017

1 reference

5

René S Kahn

1 reference

15 November 2017

Marieke Liem-Moolenaar

1

1 reference

15 November 2017

Erik T te Beek

2

1 reference

15 November 2017

Marieke L de Kam

3

1 reference

15 November 2017

Kari L Franson

4

1 reference

15 November 2017

Ron Hijman

6

1 reference

15 November 2017

Daan Touw

7

1 reference

15 November 2017

Joop M A van Gerven

8

1 reference

15 November 2017

language of work or name

English

0 references

publication date

8 February 2010

1 reference

Journal of Psychopharmacology

15 November 2017

1 reference

15 November 2017

24

1 reference

15 November 2017

11

1 reference

15 November 2017

1697-1708

1 reference

Comparison of ketamine-induced thought disorder in healthy volunteers and thought disorder in schizophrenia

15 November 2017

1 reference

https://api.crossref.org/works/10.1177%2F0269881109358200

Multicentre performance evaluation of the E170 module for modular analytics.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881109358200

Degree of inhibition of cortical acetylcholinesterase activity and cognitive effects by donepezil treatment in Alzheimer's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881109358200

Alcohol promotes dopamine release in the human nucleus accumbens

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881109358200

Delta 9-tetrahydrocannabinol induces dopamine release in the human striatum

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881109358200

Psychedelic effects of ketamine in healthy volunteers: relationship to steady-state plasma concentrations

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881109358200

Ventral striatal dopamine release in response to smoking a regular vs a denicotinized cigarette

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881109358200

Smoking-induced ventral striatum dopamine release

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881109358200

Lamotrigine (BW430C), a potential anticonvulsant. Effects on the central nervous system in comparison with phenytoin and diazepam

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881109358200

Small effect of dopamine release and no effect of dopamine depletion on [18F]fallypride binding in healthy humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881109358200

Effects of haloperidol on the behavioral, subjective, cognitive, motor, and neuroendocrine effects of Delta-9-tetrahydrocannabinol in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881109358200

The Psychotomimetic Effects of Intravenous Delta-9-Tetrahydrocannabinol in Healthy Individuals: Implications for Psychosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881109358200

Pharmacodynamic and pharmacokinetic effects of MK-0343, a GABA(A) alpha2,3 subtype selective agonist, compared to lorazepam and placebo in healthy male volunteers

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881109358200

Biomarkers for the effects of benzodiazepines in healthy volunteers

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881109358200

Biomarkers for the effects of antipsychotic drugs in healthy volunteers

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881109358200

Amphetamine-induced dopamine release in human ventral striatum correlates with euphoria.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881109358200

Endocannabinoid signaling system and brain reward: emphasis on dopamine

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881109358200

Marijuana's interaction with brain reward systems: update 1991.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881109358200

Saccadic peak velocity and EEG as end-points for a serotonergic challenge test.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881109358200

Zopiclone produces effects on human performance similar to flurazepam, lormetazepam and triazolam

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881109358200

Pharmacokinetics and pharmacodynamics of cannabinoids

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881109358200

Mu-receptor agonism with alfentanil increases striatal dopamine D2 receptor binding in man.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881109358200

Prospective cohort study of cannabis use, predisposition for psychosis, and psychotic symptoms in young people

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881109358200

An experimental study of catechol-o-methyltransferase Val158Met moderation of delta-9-tetrahydrocannabinol-induced effects on psychosis and cognition.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881109358200

Cannabinoid physiology and pharmacology: 30 years of progress.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881109358200

NEURAL MECHANISMS OF ADDICTION: The Role of Reward-Related Learning and Memory

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881109358200

Central nervous system effects of moxonidine experimental sustained release formulation in patients with mild to moderate essential hypertension.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881109358200

Occupancy of striatal and extrastriatal dopamine D2/D3 receptors by olanzapine and haloperidol

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881109358200

Role of dopamine in learning and memory: implications for the treatment of cognitive dysfunction in patients with Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881109358200

Reduced Stroop interference for opponent colors may be due to input factors: evidence from individual differences and a neural network simulation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881109358200

Cannabinoids Potentiate Emotional Learning Plasticity in Neurons of the Medial Prefrontal Cortex through Basolateral Amygdala Inputs.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881109358200

Marijuana and cannabinoid regulation of brain reward circuits

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881109358200

Dopaminergic enhancement of cognitive function

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881109358200

Positron emission tomography imaging of amphetamine-induced dopamine release in the human cortex: a comparative evaluation of the high affinity dopamine D2/3 radiotracers [11C]FLB 457 and [11C]fallypride

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881109358200

The action of sedatives on brain stem oculomotor systems in man

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881109358200

Intravenous Injection in Man of Δ 9 -Tetrahydrocannabinol and 11-OH-Δ 9 -Tetrahydrocannabinol

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881109358200

How does drug and alcohol misuse develop among people with psychotic illness? A literature review

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881109358200

The acute effects of cannabinoids on memory in humans: a review

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881109358200

Amphetamine-induced displacement of [18F] fallypride in striatum and extrastriatal regions in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881109358200

Sex differences in amphetamine-induced displacement of [(18)F]fallypride in striatal and extrastriatal regions: a PET study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881109358200

Acute effects of delta-9-tetrahydrocannabinol on dopaminergic activity in several rat brain areas

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881109358200

PET study of competition between intravenous cocaine and [11C]raclopride at dopamine receptors in human subjects.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881109358200

Antipsychotic Drugs: Direct Correlation Between Clinical Potency and Presynaptic Action on Dopamine Neurons

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881109358200

Can recreational doses of THC produce significant dopamine release in the human striatum?

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881109358200

Modelling of the concentration--effect relationship of THC on central nervous system parameters and heart rate -- insight into its mechanisms of action and a tool for clinical research and development of cannabinoids

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881109358200

Cannabinoids: reward, dependence, and underlying neurochemical mechanisms--a review of recent preclinical data

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881109358200

No evidence of the usefulness of eye blinking as a marker for central dopaminergic activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881109358200

Pharmacokinetic/pharmacodynamic assessment of tolerance to central nervous system effects of a 3 mg sustained release tablet of rilmenidine in hypertensive patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881109358200

The sensitivity of pharmacodynamic tests for the central nervous system effects of drugs on the effects of sleep deprivation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881109358200

Dopamine, learning and motivation

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881109358200

Heterogeneous effects of alcohol on dopamine release in the striatum: a PET study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881109358200

Biomarkers for the effects of cannabis and THC in healthy volunteers

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881109358200

Pharmacodynamic and pharmacokinetic effects of the intravenously administered CB1 receptor agonist Org 28611 in healthy male volunteers

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881109358200

Effect of intrapulmonary tetrahydrocannabinol administration in humans.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881109358200

21 January 2018

Identifiers

DOI

10.1177/0269881109358200

1 reference

15 November 2017

1 reference